116 related articles for article (PubMed ID: 9520908)
1. Increased total 7 alpha-hydroxy-dehydroepiandrosterone in serum of patients with Alzheimer's disease.
Attal-Khémis S; Dalmeyda V; Michot JL; Roudier M; Morfin R
J Gerontol A Biol Sci Med Sci; 1998 Mar; 53(2):B125-32. PubMed ID: 9520908
[TBL] [Abstract][Full Text] [Related]
2. Neurosteroids: Cerebrospinal fluid levels for Alzheimer's disease and vascular dementia diagnostics.
Kim SB; Hill M; Kwak YT; Hampl R; Jo DH; Morfin R
J Clin Endocrinol Metab; 2003 Nov; 88(11):5199-206. PubMed ID: 14602750
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous determination of dehydroepiandrosterone and its 7-oxygenated metabolites in human serum by high-resolution gas chromatography--mass spectrometry.
Matsuzaki Y; Yoshida S; Honda A; Miyazaki T; Tanaka N; Takagiwa A; Fujimoto Y; Miyazaki H
Steroids; 2004 Dec; 69(13-14):817-24. PubMed ID: 15582537
[TBL] [Abstract][Full Text] [Related]
4. Decreased dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) concentrations in plasma of Alzheimer's disease (AD) patients.
Aldred S; Mecocci P
Arch Gerontol Geriatr; 2010; 51(1):e16-8. PubMed ID: 19665809
[TBL] [Abstract][Full Text] [Related]
5. A lead study on oxidative stress-mediated dehydroepiandrosterone formation in serum: the biochemical basis for a diagnosis of Alzheimer's disease.
Rammouz G; Lecanu L; Aisen P; Papadopoulos V
J Alzheimers Dis; 2011; 24 Suppl 2():5-16. PubMed ID: 21335661
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of 7-hydroxylated dehydroepiandrosterone (DHEA) metabolites and selected amino-thiols as discriminatory tools of Alzheimer's disease and vascular dementia.
Bicíková M; Rípová D; Hill M; Jirák R; Havlíková H; Tallová J; Hampl R
Clin Chem Lab Med; 2004 May; 42(5):518-24. PubMed ID: 15202788
[TBL] [Abstract][Full Text] [Related]
7. In vitro metabolism of dehydroepiandrosterone (DHEA) to 7alpha-hydroxy-DHEA and Delta5-androstene-3beta,17beta-diol in specific regions of the aging brain from Alzheimer's and non-demented patients.
Weill-Engerer S; David JP; Sazdovitch V; Liere P; Schumacher M; Delacourte A; Baulieu EE; Akwa Y
Brain Res; 2003 Apr; 969(1-2):117-25. PubMed ID: 12676372
[TBL] [Abstract][Full Text] [Related]
8. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S) in Alzheimer's disease and in cerebrovascular dementia.
Yanase T; Fukahori M; Taniguchi S; Nishi Y; Sakai Y; Takayanagi R; Haji M; Nawata H
Endocr J; 1996 Feb; 43(1):119-23. PubMed ID: 8732462
[TBL] [Abstract][Full Text] [Related]
9. Change of 7alpha-hydroxy-dehydroepiandrosterone levels in serum of mice treated by cytochrome P450-modifying agents.
Attal-Khémis S; Dalmeyda V; Morfin R
Life Sci; 1998; 63(17):1543-53. PubMed ID: 9808065
[TBL] [Abstract][Full Text] [Related]
10. Increased serum levels of dehydroepiandrosterone (DHEA) and interleukin-6 (IL-6) in women with mild to moderate Alzheimer's disease.
Rasmuson S; Näsman B; Olsson T
Int Psychogeriatr; 2011 Nov; 23(9):1386-92. PubMed ID: 21729423
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress-mediated DHEA formation in Alzheimer's disease pathology.
Brown RC; Han Z; Cascio C; Papadopoulos V
Neurobiol Aging; 2003; 24(1):57-65. PubMed ID: 12493551
[TBL] [Abstract][Full Text] [Related]
12. The identification and simultaneous quantification of 7-hydroxylated metabolites of pregnenolone, dehydroepiandrosterone, 3beta,17beta-androstenediol, and testosterone in human serum using gas chromatography-mass spectrometry.
Hill M; Havlíková H; Vrbíková J; Kancheva R; Kancheva L; Pouzar V; Cerný I; Stárka L
J Steroid Biochem Mol Biol; 2005 Jul; 96(2):187-200. PubMed ID: 15908198
[TBL] [Abstract][Full Text] [Related]
13. A novel radioimmunoassay of 7-oxo-DHEA and its physiological levels.
Kazihnitková H; Zamrazilová L; Hill M; Lapcík O; Pouzar V; Hampl R
Steroids; 2007 Apr; 72(4):342-50. PubMed ID: 17298836
[TBL] [Abstract][Full Text] [Related]
14. Antiglucocorticoid effects of DHEA-S in Alzheimer's disease.
Leblhuber F; Windhager E; Neubauer C; Weber J; Reisecker F; Dienstl E
Am J Psychiatry; 1992 Aug; 149(8):1125-6. PubMed ID: 1344027
[No Abstract] [Full Text] [Related]
15. Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia.
Bernardi F; Lanzone A; Cento RM; Spada RS; Pezzani I; Genazzani AD; Luisi S; Luisi M; Petraglia F; Genazzani AR
Eur J Endocrinol; 2000 May; 142(5):466-71. PubMed ID: 10802523
[TBL] [Abstract][Full Text] [Related]
16. Studies of the enzyme complex responsible for pregnenolone and dehydroepiandrosterone 7 alpha-hydroxylation in mouse tissues.
Doostzadeh J; Morfin R
Steroids; 1996 Oct; 61(10):613-20. PubMed ID: 8910975
[TBL] [Abstract][Full Text] [Related]
17. C16 hydroxylation of 3beta-hydroxy-delta5-steroids during the early neonatal period.
Tagawa N; Kusuda S; Kobayashi Y
Biol Pharm Bull; 1997 Dec; 20(12):1295-9. PubMed ID: 9448107
[TBL] [Abstract][Full Text] [Related]
18. Immunoassay of 7-hydroxysteroids: 2. Radioimmunoassay of 7alpha-hydroxy-dehydroepiandrosterone.
Lapcík O; Hampl R; Hill M; Stárka L
J Steroid Biochem Mol Biol; 1999 Dec; 71(5-6):231-7. PubMed ID: 10704912
[TBL] [Abstract][Full Text] [Related]
19. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
Labrie F; Bélanger A; Cusan L; Candas B
J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
[TBL] [Abstract][Full Text] [Related]
20. Role of DHEA and DHEA-S in Alzheimer's disease.
Adinoff B; Martin PR; Eckardt MJ; Linnoila M
Am J Psychiatry; 1993 Sep; 150(9):1432-3. PubMed ID: 8352366
[No Abstract] [Full Text] [Related]
[Next] [New Search]
